Literature DB >> 31243133

Marek's Disease Virus RLORF4 Inhibits Type I Interferon Production by Antagonizing NF-κB Activation.

Yongzhen Liu1, Li Gao1, Zengkun Xu1, Dan Luo1, Yu Zhang1, Yulong Gao1, Changjun Liu1, Yanping Zhang1, Xiaole Qi1, Hongyu Cui1, Kai Li2, Xiaomei Wang2.   

Abstract

Marek's disease virus (MDV), which causes T cell lymphomas in chickens, is economically important and has contributed to knowledge of herpesvirus-associated oncogenicity. The DNA-sensing pathway induces innate immune responses against DNA virus infection, and nuclear factor κB (NF-κB) signaling is critical for the establishment of innate immunity. Here, we report that RLORF4, an MDV-specific protein directly involved in viral attenuation, is an inhibitor of the DNA-sensing pathway. The results showed that ectopically expressed RLORF4 blocked beta interferon (IFN-β) promoter activation induced by cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). RLORF4 selectively inhibited the activation of NF-κB but not IFN-regulatory factor 7. RLORF4 was found to bind the endogenous NF-κB subunits p65 and p50, and it also bound to the Rel homology domains of these subunits. Furthermore, RLORF4 suppressed the nuclear translocation of p65 and p50 mediated by tumor necrosis factor alpha and interferon-stimulatory DNA. Finally, deletion of RLORF4 from the MDV genome promoted IFN-β and interleukin-6 (IL-6) production in vitro and in vivo In the absence of RLORF4, the host cellular immunity was significantly increased, and reduced viral titers were observed during infection of chickens. Our results suggest that the RLORF4-mediated suppression of the host antiviral innate immunity might play an important role in MDV pathogenesis.IMPORTANCE Marek's disease virus (MDV) RLORF4 has been shown to be directly involved in the attenuation of MDV upon serial passages in vitro; however, the exact function of this protein during viral infection was not well characterized. This study demonstrated that RLORF4 significantly inhibits cGAS-STING-mediated NF-κB activation by binding to the Rel homology domains of the NF-κB subunits p65 and p50, interrupting their translocation to the nuclei and thereby inhibiting IFN-β production. Furthermore, RLORF4 deficiency promoted the induction of IFN-β and downstream IFN-stimulated genes during MDV infection in chickens. Our results suggest that the contribution of RLORF4 to MDV virulence may stem from its inhibition of viral DNA-triggered IFN-β responses.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  DNA sensing; Marek’s disease virus; NF-κB; RLORF4; innate immunity

Mesh:

Substances:

Year:  2019        PMID: 31243133      PMCID: PMC6714809          DOI: 10.1128/JVI.01037-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Immune responses to Marek's disease virus infection.

Authors:  K A Schat; C J Markowski-Grimsrud
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 3.  Evolution of the herpesviruses.

Authors:  Andrew J Davison
Journal:  Vet Microbiol       Date:  2002-04-22       Impact factor: 3.293

Review 4.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

Authors:  Giuseppina Bonizzi; Michael Karin
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

Review 5.  Introduction to NF-kappaB: players, pathways, perspectives.

Authors:  T D Gilmore
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder; Venugopal K Nair; Karel A Schat
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek's disease virus genome: the importance of vIL-8 exon I.

Authors:  Keith William Jarosinski; Karel Antoni Schat
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

8.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Authors:  Chuan-Jin Wu; Dietrich B Conze; Tao Li; Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

9.  Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.

Authors:  Stephen J Spatz; Robert F Silva
Journal:  Virus Genes       Date:  2006-09-09       Impact factor: 2.198

10.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

View more
  5 in total

Review 1.  Redox Homeostasis in Poultry: Regulatory Roles of NF-κB.

Authors:  Peter F Surai; Ivan I Kochish; Michael T Kidd
Journal:  Antioxidants (Basel)       Date:  2021-01-28

Review 2.  Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses.

Authors:  Hongnuan Wang; Wei Li; Shijun J Zheng
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 3.  Pathogenesis of Hypervirulent Fowl Adenovirus Serotype 4: The Contributions of Viral and Host Factors.

Authors:  Zeng Wang; Jun Zhao
Journal:  Viruses       Date:  2019-08-12       Impact factor: 5.048

Review 4.  Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses.

Authors:  Zhe Ge; Shuzhe Ding
Journal:  Front Cell Infect Microbiol       Date:  2022-09-14       Impact factor: 6.073

5.  IFNα and IFNγ Impede Marek's Disease Progression.

Authors:  Luca D Bertzbach; Olof Harlin; Sonja Härtle; Frank Fehler; Tereza Vychodil; Benedikt B Kaufer; Bernd Kaspers
Journal:  Viruses       Date:  2019-11-28       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.